Plasma visfatin levels in severe obstructive sleep apnea—hypopnea syndrome

Background Obstructive sleep apnea syndrome (OSAS) is associated with obesity and insulin resistance. Visfatin is an insulin-mimicking adipokine, which is considered a link between obesity and insulin resistance. Aim of this study was to evaluate levels of plasma visfatin in patients with severe OSA...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sleep & breathing 2009-11, Vol.13 (4), p.349-355
Hauptverfasser: Trakada, Georgia, Steiropoulos, Paschalis, Nena, Evangelia, Gkioka, Theodora, Kouliatsis, Georgios, Pataka, Athanasia, Sotiriou, Ioannis, Anevlavis, Stavros, Papanas, Nikolaos, Bouros, Demosthenes
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Obstructive sleep apnea syndrome (OSAS) is associated with obesity and insulin resistance. Visfatin is an insulin-mimicking adipokine, which is considered a link between obesity and insulin resistance. Aim of this study was to evaluate levels of plasma visfatin in patients with severe OSAS and examine their potential correlation with sleep characteristics and several biochemical parameters. Methods Nondiabetic patients with severe OSAS (Apnea Hypopnea Index > 30/h, n  = 32) and healthy controls (Apnea Hypopnea Index 
ISSN:1520-9512
1522-1709
DOI:10.1007/s11325-009-0254-6